News

Zacks Investment Research on MSN12h
CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $38.54, marking a -1.76% move from the previous day. This change lagged the S&P 500's daily gain of 1.67%. Elsewhere, the Dow saw ...
STAT21h
CRISPR’s CEO got a big payday
Bristol Myers Squibb’s new treatment for schizophrenia didn’t provide additional benefits to patients when given on top of ...
GEN - Genetic Engineering and Biotechnology News1d
The State of CRISPR and Genome Editing
In The State of CRISPR and Genome Editing virtual summit, GEN brings together an outstanding line-up of pioneers and ...
‘Incoming Regulatory Tailwinds’ to Spur 90% Upside for CRISPR Therapeutics Stock, Says BMO Capital
Gene therapy developer CRISPR Therapeutics AG (CRSP) is navigating some regulatory and commercial dynamics. Its flagship gene ...
Pharmaceutical Technology on MSN6d
Bluebird bio reaffirms Carlyle deal as Ayrmid misses deadline
Bluebird bio (bluebird) has reaffirmed its support for a proposed acquisition by Carlyle and SK Capital after rival bidder ...